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A B S T R A C T
Cell-penetrating peptides (CPPs) are prominent delivery vehicles to confer cellular entry of (bio-) macro-
molecules. Internalization eﬃciency and uptake mechanism depend, next to the type of CPP and cargo, also on
cell type. Direct penetration of the plasma membrane is the preferred route of entry as this circumvents
endolysosomal sequestration. However, the molecular parameters underlying this import mechanism are still
poorly deﬁned. Here, we make use of the frequently used HeLa and HEK cell lines to address the role of lipid
composition and membrane potential. In HeLa cells, at low concentrations, the CPP nona-arginine (R9) enters
cells by endocytosis. Direct membrane penetration occurs only at high peptide concentrations through a
mechanism involving activation of sphingomyelinase which converts sphingomyelin into ceramide. In HEK cells,
by comparison, R9 enters the cytoplasm through direct membrane permeation already at low concentrations.
This direct permeation is strongly reduced at room temperature and upon cholesterol depletion, indicating a
complex dependence on membrane ﬂuidity and microdomain organisation. Lipidomic analyses show that in
comparison to HeLa cells HEK cells have an endogenously low sphingomyelin content. Interestingly, direct
permeation in HEK cells and also in HeLa cells treated with exogenous sphingomyelinase is independent of
membrane potential. Membrane potential is only required for induction of sphingomyelinase-dependent uptake
which is then associated with a strong hyperpolarization of membrane potential as shown by whole-cell patch
clamp recordings. Next to providing new insights into the interplay of membrane composition and direct
permeation, these results also refute the long-standing paradigm that transmembrane potential is a driving force
for CPP uptake.
1. Introduction
Cell-penetrating peptides (CPPs) are emerging drug delivery vehi-
cles because of their capacity to induce eﬃcient cellular uptake of
molecules that otherwise do not enter cells [1]. In order to enable a
rational optimization of CPPs and understand cell type preference, CPP
entry mechanisms have been intensely investigated. The mode of entry
depends on peptide concentration, cell type and the conjugated cargo
[2–5] but also on structural characteristics of the peptide such as amino
acid charge and stereochemistry [6]. At low micromolar concentra-
tions, arginine-rich CPPs are mainly endocytosed, whereas rapid
cytoplasmic entry can occur at high concentrations [7]. This entry is
associated with the accumulation of peptide at certain membrane areas,
called nucleation zones (NZ), which are colocalizing with ceramide
platforms [8–10]. Uptake via NZ is restricted to arginine-rich CPPs such
as nona-arginine [8], with the human lactoferrin-derived CPP being a
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remarkable exception as this peptide only has four arginine residues
[11].
Although the mechanism of CPP internalization has been described
to be cell line-dependent, the reasons for these diﬀerences are unknown
[4]. A considerable amount of research has been conducted on the role
of glycosaminoglycans (GAGs) in endocytosis since these are the ﬁrst
(negatively) charged molecules that cationic CPPs encounter when
approaching a cell [12,13]. Several studies demonstrated a positive
eﬀect of GAGs on CPP internalization [8,14–16]. However, the role of
GAGs depends on the type of CPP, and GAGs are probably not acting as
autonomous receptors but rather as coreceptors as reviewed by Favretto
et al. [13]. This hypothesis is further supported by the ﬁnding that in
the absence of GAGs, CPPs still bind to the cells and are internalized
[17]. Furthermore, the membrane potential (Vmem) has been considered
a driving force for the internalization of cationic CPPs [18,19].
In direct comparisons of the frequently used cell lines HEK and HeLa
we had observed that HEK cells showed a direct cytoplasmic peptide
uptake at concentrations at which HeLa cells only showed endocytosis
[20,21]. In this study, we made use of these earlier observations to
elucidate the molecular and cellular characteristics underlying the
diﬀerence in uptake mechanisms between these cell lines with regard
to the occurrence of direct translocation at low peptide concentrations
and nucleation zone-dependent uptake.
Using electrophysiological recordings in living cells during peptide
internalization we show that both cell lines diﬀer fundamentally in
their membrane characteristics. In HEK cells, direct membrane translo-
cation was independent of membrane potential. By contrast, an intact
resting membrane potential was required for the induction of nuclea-
tion zones in HeLa cells and, remarkably, this process was associated
with a sudden hyperpolarization of the plasma membrane. Lipidomics
revealed that, in contrast to HeLa cells, membranes of HEK cells have a
low sphingomyelin content, and conversion of sphingomyelin into
ceramide further enhances membrane translocation. A role of mem-
brane ﬂuidity and membrane microdomain organisation was estab-
lished by demonstrating that in HEK cells direct permeation is
abolished at room temperature and upon cholesterol depletion. These
results also resolve a long-standing dispute according to which ﬂuor-
escent labelling is incompatible with direct membrane permeation [22],
and shall open new directions of research into the interdependence of
membrane composition and permeation of macromolecules.
2. Materials and methods
2.1. Materials
Unless stated otherwise, all compounds were obtained from Sigma-
Aldrich and cell culture materials from Invitrogen. The used sphingo-
myelinase (bSMase) is derived from Bacillus cereus and provided at a
concentration of 138 U/mL. Stock solutions of valinomycin (9 mM) and
gramicidin A (1.06 mM) were prepared in DMSO and ethanol, respec-
tively.
2.2. Cell culture
HeLa and HEK293T cells were obtained from the DSMZ (German
Collection of Microorganisms and Cell Cultures, Braunschweig,
Germany). HeLa cells were cultured in RPMI supplemented with 10%
fetal calf serum (FCS) whereas HEK cells were maintained in high
glucose DMEM containing 10% FCS. Both cell lines were cultivated in
an incubator at 37 °C with 5% CO2. Cell culture media were purchased
from Invitrogen.
2.3. Peptides
For translocation experiments in large unilamellar vesicles, peptides
were synthesized on an automated Syro II multiple peptide synthesizer
(MultiSynTech, Witten, Germany), using standard solid phase Fmoc
protocols. Peptide synthesis reagents, Fmoc-protected amino acids, and
7-(9-Fluorenylmethyloxycarbonylamino)-coumarin-4-acetic acid (Fmoc-
ACA-OH) were purchased from Merck Biosciences (Darmstadt,
Germany) and/or Iris Biotech (Marktredwitz, Germany). Solvents for
peptide synthesis were purchased from Merck (Darmstadt, Germany) or
from Biosolve (Valkenswaard, Netherlands), and solvents for HPLC
puriﬁcation were obtained from Fischer Scientiﬁc (Geel, Belgium). The
C-terminal phenylalanine of each peptide sequence carried a 7-amino-4-
methylcarbamoylcoumarin (ACC) moiety that experiences a wavelength
shift upon chymotrypsin cleavage. ACC-resin synthesis was performed
manually prior to the peptide synthesis [23]. The crude peptides were
puriﬁed using a high-pressure liquid chromatography (HPLC) device from
JASCO (Groß-Umstadt, Germany) on a preparative Vydac C18 column,
using a water/acetonitrile gradient supplemented with 5 mM HCl. The
puriﬁed peptides were characterized by using analytical HPLC (Agilent;
Waldbron, Germany) coupled to an ESI mass spectrometer (μTOF Bruker,
Bremen, Germany), and were found to be> 95% pure.
Fluorescently labelled peptides were purchased from EMC micro-
collections (Tübingen, Germany). All peptides were C-terminally ami-
dated and N-terminally labelled with 5,6-carboxyﬂuorescein or Alexa
488. Peptide concentrations were determined based on the absorbance
of ﬂuorescein at 492 nm with a Novaspec II spectrophotometer
(Pharmacia, New York, USA). Fluorescein-labelled peptides were
diluted in Tris-HCl buﬀer (10 mM, pH 8.8) and an extinction coeﬃcient
of 75,000 M−1 cm−1 was assumed for calculating peptide concentra-
tions, the Alex488-labelled peptide was diluted into deionized water
and extinction measured at 495 nm assuming an extinction coeﬃcient
of 73,000 M−1 cm−1.
2.4. Confocal laser scanning microscopy
Two days before the experiment 20,000 HeLa cells or 25,000 HEK
cells were seeded in chambered coverslips (Nunc, Wiesbaden, Germany
or Ibidi, Martinsried, Germany, respectively). Confocal microscopy was
performed using a Leica SP5 microscope with an HCX PL APO 63×
N.A. 1.2 water immersion lens (Leica, Mannheim, Germany). During
image acquisition, cells were maintained at 37 °C. Fluorescein was
excited using an argon ion laser at 488 nm and emission was collected
between 500 and 550 nm. Cells were incubated with the indicated
peptide concentrations and the speciﬁc compounds, as indicated for
each experiment. During imaging, cells were maintained in RPMI
without phenol red in the presence or absence of 10% FCS.
2.5. Flow cytometry
80,000 HeLa cells or 100,000 HEK cells were seeded in 24-well
plates one day before the experiment. After incubating cells for 10 min
either with 1 μM gramicidin A or 10 μM valinomycin in RPMI or RPMI
alone, cells were co-incubated for 20 min with the indicated peptide
concentrations. Cells were washed with RPMI twice, trypsinized,
centrifuged and resuspended in RPMI + 10% FCS without phenol
red. Fluorescence intensities were measured using a ﬂow cytometer
(BD Biosciences, Erembodegem, Belgium). Approximately 10,000 intact
cells were gated based on forward and sideward scatter. The Summit
4.3 software (Dako, Fort Collins, USA) was used for the analysis of
gated cells.
2.6. Patch-clamp combined with confocal laser scanning microscopy
For electrophysiological recordings, HEK293T cells or HeLa cells
were cultured on 35 mm glass dishes and transferred to a recording
chamber (Luigs & Neumann, Ratingen, Germany) on an upright ﬁxed-
stage scanning confocal microscope (TCS SP5 DM6000CFS, Leica
Microsystems, Mannheim, Germany) equipped with an HCX APO L
20 × NA 1.0 water immersion objective (Leica Microsystems) as well as
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a cooled CCD-camera (DFC360FX, Leica Microsystems). Fluorescein
was excited using the 488 nm line of an argon ion laser. Changes in
cytosolic ﬂuorescence were monitored over time at 0.25–1 Hz frame
rates. Patch pipettes (4–7 MΩ) were pulled from borosilicate glass
capillaries (1.50 mm OD / 0.86 mm ID; Science Products, Hofheim,
Germany) on a PC-10 micropipette puller (Narishige Instruments,
Tokyo, Japan), ﬁre-polished (MF-830 Microforge; Narishige
Instruments) and ﬁlled with pipette solution containing 143 mM KCl,
2 mM KOH, 1 mM EGTA, 0.3 mM CaCl2 (free Ca2+ = 110 nM), 10 mM
HEPES, 2 mM MgATP, 1 mM NaGTP; pH = 7.1 (adjusted with KOH);
osmolarity = 290 mOsm. An agar bridge (150 mM KCl) connected the
reference electrode and the bath solution. An EPC-10 ampliﬁer
controlled by Patchmaster 2.67 software (HEKA Elektronik,
Lambrecht, Germany) was used for data acquisition. Both pipette
(Cfast) and cell membrane capacitance (Cslow) were monitored and
automatically compensated throughout the experiment. If not stated
otherwise, signals were low-pass ﬁltered (analog 3- and 4-pole Bessel
ﬁlters (−3 dB); adjusted to 1/3–1/5 of the sampling rate (5–10 kHz,
depending on protocol)). Electric noise was suppressed using a Hum
Bug Noise Eliminator (Quest Scientiﬁc, Vancouver, Canada). Between
recordings, the holding potential (Vhold) was −60 mV. All electrophy-
siological data were recorded in whole-cell conﬁguration at room
temperature. Free Ca2+ and Mg2+ concentrations were calculated
using WEBMAXC STANDARD (available at http://www.stanford.edu/
~cpatton/webmaxcS.htm). Cells were continuously superfused with
extracellular solution containing 145 mM NaCl, 5 mM KCl, 1 mM CaCl2,
1 mM MgCl2, 10 mM HEPES; pH = 7.3 (adjusted with NaOH);
osmolarity = 300 mOsm (adjusted with glucose). Stimuli were applied
from air pressure-driven reservoirs via an 8-in-1 multi-barrel ‘perfusion
pencil’ (Science Products, Hofheim, Germany) [24]. Individual numbers
of cells / experiments (n) are denoted in the ﬁgure legends. If not stated
otherwise, results are presented as means ± SEM and statistical
analyses were performed using paired or unpaired t-tests (as dictated
by experimental design). Electrophysiological data were analyzed oﬀ-
line using Patchmaster 2.67 (HEKA Elektronik), IGOR Pro 6.31 (Wave-
Metrics, Lake Oswego, OR) and Excel (Microsoft, Seattle, WA) software.
2.7. Plasma membrane isolation and lipid analysis
The protocol for extraction of lipids from the plasma membrane was
adjusted from Yao et al. [25]. One million cells were seeded in petri
dishes (145 mm) and grown for four days. Cells were washed twice with
ice-cold HBS+ (10 mM HEPES, 135 mM NaCl, 5 mM KCl, 1 mM MgCl2,
1.8 mM CaCl2, pH 7.4, containing protease inhibitor cocktail (Roche,
Basel Switzerland) and 1 mM phenylmethylsulfonyl ﬂuoride (Sigma-
Aldrich, St. Louis, USA)) and scraped into HBS+. Cells from three petri
dishes were pooled and homogenized with an Ultra Turrax (IKA T10
basic, IKA-Werke, Staufen, Germany) 3 times for 5 s with 1 min pause.
A Bradford assay (Biorad, München, Germany) was performed to
normalize for the protein content of the samples.
Cell lysates were centrifuged at 10,000 ×g for 45 min at 4 °C using
an ultracentrifuge (Sorvall WX80, Thermo Scientiﬁc, Waltham, USA).
This ultracentrifuge was also used for all subsequent centrifugation
steps at 4 °C. Membrane pellets were resuspended in 5% sucrose (in
HBS+). Sample volumes corresponding to the same protein amounts
were loaded onto a sucrose gradient (45%–20%–5%) and centrifuged
overnight at 150,000 ×g at 4 °C in a swing-out rotor. The plasma
membrane fraction, which was located on top of the 45% and inside the
20% layer, was diluted with HBS+ and centrifuged for 30 min at
200,000 ×g. After resuspending the pellet in 5% sucrose, it was loaded
again onto a sucrose gradient and centrifuged for 1 h at 200,000 ×g
using a swing-out rotor. The plasma membrane fraction was collected at
the interface of the 45% and 20% layers. The pellet was diluted with
milliQ, pelleted at 200,000 ×g for 30 min and resuspended in 200 μL
milliQ for lipid extraction. The lipid extraction (chloroform/methanol)
and analysis (by matrix-assisted laser desorption and ionization time-of-
ﬂight mass spectrometry) were performed according to Dinkla et al.
[26].
2.8. Uptake in large unilamellar vesicles
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol (POPG),
cholesterol (CHOL), sphingomyelin (SM, from chicken egg), and 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sul-
fonyl) (Rhod-PE) were obtained from Avanti Polar Lipids (Alabaster, USA).
The translocation experiments were based on a modiﬁed experi-
mental design according to [27], using a 10 mM PIPES-Na2 buﬀer
(pH 7.0) containing 10 mg/mL chymotrypsin and 150 mM NaCl. Lipo-
somes were prepared by dissolving the dry lipids (POPC/POPG/CHOL
at a molar ratio of 5.5/4.5/1, or POPC/POPG/CHOL/SM at 4.5/4.5/1/
1) together with 2–3 μL of rhodamine-PE in MeOH/CHCl3 (1/1 (v/v)).
The mixture was dried under a ﬂow of N2 and placed under high
vacuum overnight to remove residual solvent. The obtained thin layer
was then re-suspended in the chymotrypsin-containing buﬀer by
vortexing, followed by 10 freeze-thaw cycles using warm water
(50 °C) to form multilamellar liposomes. A uniform population of large
unilamellar vesicles (LUVs) was obtained by repeated high pressure
extrusion of the liposomes through a polycarbonate Unipore membrane
(pore size, 100 nm; Millipore) at a temperature above the gel-to-liquid
crystal phase transition (POPC/POPG at 2 °C). To remove unencapsu-
lated dye, the vesicles were puriﬁed before the experiment by gel
ﬁltration on a Sephacryl 500-HR (Sigma-Aldrich, St. Louis, MO) column
using a 10 mM PIPES-Na2/150 mM NaCl elution buﬀer, which balances
the internal vesicle osmolarity. Samples of the vesicles were taken
before and after the puriﬁcation to determine the lipid concentration by
spectroscopically determining the amount of rhodamine-PE (ex/em:
540 nm/580 nm, 5 nm slit).
The translocation of the peptides into the vesicles was quantitatively
monitored over time from the ﬂuorescence of cleaved ACC that
appeared only after contact of the peptides with the chymotrypsin
present inside the vesicles. Fluorescence measurements were performed
in a thermostated cuvette under constant stirring at 30 °C (i.e. above the
transition temperature of all lipids used) in 10 mM PIPES-Na2 (pH 7.0)
containing 150 mM NaCl on a FluoroMax2 spectroﬂuorimeter (2 nm
slit), using the spectroscopic parameters of free ACC (ex/em: 365 nm/
470 nm). The peptide was added to the cuvette containing the vesicles
after an incubation time of 100 s. The peptide concentration of the ﬁnal
sample was 1 μM with a peptide-to-lipid molar ratio (P/L) of 1:50. The
translocation rate of the peptides was determined relative to the
translocation rate of the highly membrane permeant chymotrypsin
substrate TP1 (PLILLRLLRGQF-ACC) [27] that was set to 100%. Data
were acquired in the ﬁrst 120 s after addition of the peptide to the
vesicles.
3. Results
3.1. Diﬀerential uptake routes in HeLa and in HEK cells
So far, direct membrane permeation of CPPs has primarily been
associated with cargo size and type of CPP [28]. Even though also a cell
type-dependence has been reported there is little understanding of the
cellular and molecular characteristics underlying these diﬀerences.
HeLa and HEK cells are commonly used cell lines in in vitro uptake
studies, due to their ease of handling and the large body of available
data relating to these cells. We had observed before that HEK cells
permit direct penetration of the prototypic arginine-rich CPP R9
independent of concentration [20]. To compare HeLa and HEK cells
side-by-side, cells were incubated with ﬂuorescein-labelled R9 at
diﬀerent concentrations. In HeLa cells, at low micromolar concentra-
tions uptake occurred by endocytosis (Fig. 1A). Only at peptide
concentrations exceeding 10 μM, a concentration-dependent switch to
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a rapid and very eﬃcient cytoplasmic import was observed. We have
shown before that this switch depends on the activation of acid
sphingomyelinase and ceramide formation [9]. By contrast, HEK cells
showed, independent of peptide concentration, a pronounced cytoplas-
mic ﬂuorescence and less endocytic vesicles. There was no concentra-
tion-dependent switch in import mechanism. When cell-associated
ﬂuorescence was quantiﬁed by ﬂow cytometry, these diﬀerences were
reﬂected by a linear dose dependence of uptake in HEK cells and by a
very steep increase in cell-associated ﬂuorescence in HeLa cells (see
Fig. 5A, control condition). While cytoplasmic inﬂux into HeLa cells at
high peptide concentrations occurs rapidly [8], time-lapse microscopy
showed a continuous increase of homogenous cytoplasmic and nuclear
ﬂuorescence in HEK cells. In HeLa cells, some punctate ﬂuorescence
became visible only after 10 min, consistent with uptake by endocytosis
(Fig. 1B). It has frequently been argued that the use of ﬂuorescein as a
ﬂuorophore can lead to misinterpretation due to the pH dependence of
this ﬂuorophore. In order to rule out that the absence of endocytic
vesicles for HEK cells was a consequence of pH or concentration
dependent quenching inside endosomes, the subcellular distribution
of ﬂuorescein-R9 was compared to the one of Alexa488-R9. For this
experiment we used HeLa cells as these showed prominent endocytic
uptake. The distribution of punctate ﬂuorescence for both peptides in
HeLa cells was indistinguishable, and also the degree of colocalization
with the endolysosomal probe lysotracker was the same (Supplemental
Fig. 1), thereby validating that ﬂuorescein provides a reliable detection
of endolysosomal vesicles at this time point. For Alexa488-R9, in HEK
cells, less cytoplasmic ﬂuorescence was present, and in HeLa cells NZ-
dependent uptake could only be observed at 20 μM under serum-free
conditions, which can be explained by the bulkiness and higher charge
of Alexa488 which compromises direct crossing of the plasma mem-
brane. To substantiate that the presence of cytoplasmic ﬂuorescence in
HeLa cells at high concentrations was not a function of the ﬂuorophore
but of the peptide, cells were incubated with a mixture of 2 μM labelled
peptide and 20 μM unlabelled R9. While at 2 μM of Fluo-R9 alone,
hardly any ﬂuorescence was presence, cells incubated with the mixture
showed a homogenous cytoplasmic ﬂuorescence (Supplemental Fig. 2).
To explore the scope of these diﬀerences, we also assessed the
uptake for penetratin and the D-amino acid isomer r9. In HeLa cells,
penetratin only showed a punctate ﬂuorescence independent of con-
centration [8], while endocytic uptake for r9 was only half that of R9
(Supplemental Fig. 3) [6]. In HEK cells, for r9 only homogenous
cytoplasmic staining with prominent nucleolar ﬂuorescence was pre-
sent, which is in accordance with earlier observations for this stereo-
isomer [8,29]. Clearly, direct cytoplasmic entry is chirality indepen-
dent. For penetratin, next to some punctate ﬂuorescence, also a
pronounced cytoplasmic ﬂuorescence was observed.
3.2. Both cell lines show similar glycosaminoglycan proﬁles
Since glycosaminoglycans (GAGs) and sialic acids were shown to be
involved in the internalization of CPPs [13], we were interested to learn
whether diﬀerences in the amount or proﬁle of glycosaminoglycans
Fig. 1. Diﬀerential uptake routes of nona-arginine (R9) in HeLa and HEK cells. (A) Cells were incubated with the indicated concentrations of R9 in RPMI + 10% FCS for 20 min. Cells
were washed and imaged by confocal microscopy. (B) Cells were incubated with 5 μM nona-arginine in RPMI + 10% FCS. Images were acquired by confocal microscopy during
incubation. Therefore, also some out-of-focus ﬂuorescence is present. Time points indicate the time after the start of the peptide incubation.
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between cell lines may contribute to diﬀerences in uptake mechanisms.
Therefore, we compared the glycocalyx composition of HeLa and HEK
cells using a panel of single chain antibodies with preferences for
certain GAGs (Supplemental Fig. 4A). Overall, the glycocalyx composi-
tion was similar for HeLa and HEK cells. For some epitopes, especially
for chondroitin sulfate, HEK cells showed a lower expression. However,
complete removal of the glycocalyx did not change the uptake
mechanism of R9 (Supplemental Fig. 4B), indicating that the composi-
tion of the glycocalyx is not a key determinant for the uptake
mechanism.
3.3. Lipid composition as a determinant for uptake mechanism
Next, we hypothesized that the direct membrane translocation of
nona-arginine in HEK cells may also be a consequence of a particular
lipid composition of the plasma membrane. To compare their lipid
content, plasma membranes of HeLa and HEK cells were isolated by
sucrose density centrifugation and lipids were detected using mass
spectrometry. Remarkably, while the plasma membrane of HeLa cells
was rich in sphingomyelin, hardly any sphingomyelin was detected in
the isolates of HEK cells (Fig. 2). When HeLa cells were treated with
bSMase, ceramide could be detected, which is in agreement with
immunoﬂuorescence staining in a previous study that showed coloca-
lization of NZ with ceramide [9].
3.4. Direct membrane permeation in HEK cells is sensitive to temperature
and cholesterol depletion
The results so far indicated that the plasma membrane of HeLa cells
is resistant to peptide penetration, and direct uptake can occur only
after modulation of membrane composition through sphingomyelin
turnover. In contrast, for HEK cells the membrane has an intrinsic
permissiveness for entry of R9. Temperature and cholesterol content are
key determinants for membrane organisation and ﬂuidity. Therefore,
we assessed the impact of lower temperatures on uptake. In comparison
to 37 °C, the cytoplasmic ﬂuorescence in HEK cells was strongly
decreased at 30 °C. This eﬀect was even more pronounced at room
temperature (Fig. 3A). Interestingly, cytoplasmic uptake at room
temperature could be partially rescued by incubation of cells with
sphingomyelinase (bSMase). In contrast, endocytic uptake for HeLa
cells was not aﬀected over this temperature range (Fig. 3B, D).
To determine the impact of the various conditions on endocytosis,
cells were co-stained with ﬂuorescently labelled transferrin as a marker
for clathrin-dependent endocytosis. Overall, HEK cells showed less
uptake of transferrin than HeLa cells. Remarkably, for HEK cells,
endocytic uptake even increased at lower temperatures. Similar to the
impact of temperature, for HEK cells also cholesterol extraction by
cyclodextrin treatment reduced cytoplasmic ﬂuorescence. The reduc-
tion was the strongest at 37 °C (Fig. 3C, E).
3.5. Membrane potential changes diﬀer between HeLa and HEK cells
Given its previous implication in peptide uptake [19,30], we next
addressed the role of the plasma membrane potential (Vmem) for
peptide uptake in HEK and HeLa cells. Using a combination of confocal
microscopy and single-cell patch-clamp, Vmem was recorded during
peptide uptake. We performed whole cell recordings, meaning that the
membrane patch inside the patch pipette was broken and the potential
across the whole plasma membrane was measured. Surprisingly,
nucleation zone-dependent uptake in HeLa cells was associated with a
strong hyperpolarization (Fig. 4). By comparison, in HEK cells, there
were no major changes in Vmem, except for a slight depolarization,
providing further evidence that in these two cell lines direct cytoplas-
mic uptake occurs by two fundamentally diﬀerent mechanisms. Strong
hyperpolarization was only observed in HeLa cells that showed
nucleation zones, as was conﬁrmed by randomly patching cells and
then recording their uptake kinetics. It is important to note that during
experiments nucleation zones were also observed in non-patched cells,
conﬁrming that peptide inﬂux was not a consequence of membrane
damage inﬂicted by patch-clamping the cell. Since patch-clamp record-
ings had to be performed in HEPES-buﬀered solution in the absence of
FCS, we used reduced peptide concentrations. Serum is known to
reduce the eﬀective peptide concentration due to binding to serum
proteins (Supplemental Fig. 5) [3]. The degree of hyperpolarization was
variable as is the strength of peptide uptake for NZ-dependent uptake
{[8] #355}. Therefore, no statistics can be given.
Next, we wanted to investigate whether changing Vmem aﬀected the
internalization eﬃciencies in HeLa and HEK cells. As described earlier,
valinomycin and gramicidin A induce hyperpolarization and depolar-
ization, respectively [31–33]. We were able to conﬁrm the eﬀects of
Fig. 2. Positive ion MALDI-TOF mass spectra of membrane lipid extracts from HeLa and HEK cells. Samples were diluted 1:1 (v/v) with the matrix (0.5 M 2,5-dihydroxybenzoic acid in
methanol). All peaks are labelled based on their m/z ratios and matrix cluster ions are marked by asterisks. (A) HEK cells, (B) HeLa cells, (C) HeLa cells treated for 20 min with 1200 mU/
mL bSMase at 37 °C. Cer, ceramide; PC, phosphatidylcholine; SM, sphingomyelin.
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Fig. 3. (A) Direct uptake decreases with temperature. HEK and HeLa cells were treated with 5 μM Fluo-R9 and Transferrin-Alexa633 in the presence of serum for 30 min. (B, D) bSMase
partially rescues the Fluo-R9 uptake at room temperature in HEK cells. N = 2; (C, E) Cholesterol extraction with MβCD compromises direct permeation in HEK293T cells. For microscopy,
only incubation at 37 °C is shown. Scale bars represent 20 μm. Error bars represent standard deviation.
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both compounds by whole-cell patch-clamp recordings (Supplemental
Fig. 6).
At low micromolar concentrations, manipulating Vmem did not
change the uptake eﬃciencies in either HeLa or HEK cells. However,
depolarizing Vmem using gramicidin A dramatically reduced R9 inter-
nalization at 10 μM in HeLa cells (Fig. 5). The uptake route was
completely shifted from NZ to endocytosis, indicating that NZ-depen-
dent peptide uptake in HeLa cells requires an intact resting membrane
potential, whereas endocytotic uptake does not. Hyperpolarization had
no signiﬁcant eﬀect on uptake. By contrast, changing Vmem in HEK cells
had no major eﬀect on internalization eﬃciency. The diﬀerences in cell-
associated intensities between HeLa and HEK cells show that endocytic
and, in particular, NZ-dependent uptake in HeLa cells are more eﬃcient
than the concentration-independent direct membrane translocation
occurring in HEK cells. Interestingly, in HEK cells pre-incubation with
gramicidin A even caused a slight increase in uptake eﬃciency. Thus,
the direct peptide translocation in HEK cells is independent of the
presence of a transmembrane potential, further underpinning that this
translocation is fundamentally diﬀerent from the NZ-dependent uptake
in HeLa cells.
After detecting that the formation of a nucleation zone is accom-
panied by strong hyperpolarisation, we aimed to further investigate the
molecular mechanism of NZ-dependent uptake. Current knowledge
regarding molecular uptake mechanisms is sparse except for the
involvement of acid sphingomyelinase and subsequent ceramide for-
mation [9]. However, so far the molecular details of events leading to
sphingomyelinase activation in general have remained elusive [34].
The possibility to record the membrane potential in parallel to
observing peptide uptake allowed us to investigate whether hyperpo-
larization is a prerequisite for, or a consequence of ceramide formation.
We depolarized HeLa cells with gramicidin A, which inhibits NZ-
dependent internalization of R9 (Fig. 5), under continuous monitoring
of Vmem (Fig. 6). Surprisingly, when replacing gramicidin A by bacterial
sphingomyelinase (bSMase), we observed rapid cytoplasmic uptake
while Vmem remained depolarized. These ﬁndings show that an intact
resting potential is required for triggering sphingomyelinase activation,
but once sphingomyelin is converted to ceramide, entry occurs in a
potential-independent manner.
3.6. Uptake into large unilamellar vesicles
Considering the prominent role of sphingomyelin in the control of
membrane permeation we were interested to learn whether these
eﬀects could be recapitulated in large unilamellar vesicles as a
Fig. 4. Membrane potential during R9 internalization in HeLa and HEK cells. (A) Uptake of 10 μM R9 in HEPES buﬀer into representative patched cells over time. Scale bars denote
10 μm. (B) The mean ﬂuorescent intensities (MFI) of cells (in A) are plotted over time. Note that ﬂuorescence for the patched HeLa cell went into saturation. In this case, confocal
microscopy did not intend to provide quantitative information on uptake, but time-resolved data on the onset of NZ-dependent uptake. (C) Membrane potential recordings of the patched
cells over time. Graphs in B and C correspond to the cells shown in A. Due to the low numerical aperture of the lens required during patch clamp recordings, images show more out-of-
focus ﬂuorescence. Shown is one representative cell for each type of a total of about ten.
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minimalistic model system. Using the protocol by Marks et al. [27],
uptake was determined into vesicles consisting of a mixture of
palmitoyl-oleoyl-phosphatidylcholine (POPC), -glycerol (POPG) and
cholesterol, which were prepared with and without sphingomyelin.
Initial experiments had shown that the anionic POPG was a prerequisite
for the observation of uptake. CPPs were synthesized with a C-terminal
aminomethylcarbamoylcoumarin ﬂuorogenic group, linked to the pep-
tide via a chymotrypsin cleavage site. Liposomes were loaded with the
protease. Outside the liposomes a protease inhibitor prevented peptide
cleavage, in case any enzyme was released from the liposomes as a
consequence of membrane disruption. Next to R9 we also included
penetratin in our analyses, and we used the highly amphipathic and
membrane-active CPP TP1 as an established “gold standard” for this
assay [27]. TP1 indeed showed the highest uptake, followed by R9 and
penetratin. Interestingly, there was no dependence of uptake on the
presence of sphingomyelin (Supplemental Fig. 7).
4. Discussion
In this study we show that direct permeation of R9 through the
plasma membrane occurs independent of transmembrane potential. By
comparing uptake in HEK and HeLa cells and analyzing their plasma
membrane characteristics, we identify sphingomyelin content as an
important diﬀerence. In HeLa cells, direct cytoplasmic entry requires
the conversion of sphingomyelin into ceramide. Once this conversion
has occurred, the kinetics and extent of peptide entry exceeds the one
for HEK cells. This conversion may either occur through activation of
endogenous acid sphingomyelinase at high peptide concentrations or
through addition of exogenous sphingomyelinase. Only for the trigger-
ing of endogenous sphingomyelinase, an intact resting membrane
potential is required.
Direct translocation in HEK cells responds sensitively to a lowering
of temperature. Also changes in membrane microdomain organisation
through cholesterol extraction abolish direct translocation. These data
also underline that cytoplasmic ﬂuorescence results from direct mem-
brane permeation and does not reﬂect any release of degraded peptide
from endosomes. It has been argued that inside endosomes ﬂuorescein
may be quenched so that endosomes become invisible. Our experi-
ments, using Alexa488-labelled R9 clearly refute this point. For this
reason, the lack of endosomal ﬂuorescence in HEK cells cannot be due
to quenching of ﬂuorescence. We were surprised ourselves by the
similarity of the degree of colocalization for the ﬂuorescein- and
Alexa488-labelled peptides. This observation may be attributed to the
fact that we address uptake during the ﬁrst 30 min of incubation when
peptides should still be located in early and sorting endosomes.
Importantly, direct membrane permeation was observed for a ﬂuor-
escein-labelled peptide. It had been argued before that a ﬂuorophore
interferes with this uptake route [22]. Furthermore, it had been
reported that ﬂuorescein labelled peptides may lead to misinterpreta-
tions of peptide localization due to quenching of membrane associated
Fig. 5. Impact of membrane potential changes on uptake eﬃciencies of R9. HeLa and HEK cells were pre-incubated with the indicated compounds or RPMI alone for 10 min which was
followed by a 20 min co-incubation with the indicated concentrations of R9. (A) After the incubation, cells were washed, trypsinized and analyzed by ﬂow cytometry. Averages of median
ﬂuorescence intensities of three independent experiments are shown. Error bars denote SEM. (B) After incubating with 10 μM R9, cells were washed and imaged using confocal
microscopy. Scale bar denotes 40 μm.
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peptides [35]. We were not able to recapitulate these ﬁndings. Instead,
our data demonstrated that unlabelled peptide drives the cytoplasmic
uptake of ﬂuorescently labelled peptides.
Our lipidomic analyses show that, in contrast to HeLa cells, the
plasma membrane of HEK cells contains only small amounts of
sphingomyelin, thus indicating that sphingomyelin is a key determinant
for control of the permissiveness of the membrane towards peptide
transport. Importantly, as a consequence of the scarcity of sphingo-
myelin in HEK cell membranes, only small amounts of ceramide can be
formed. Nevertheless, conversion of these small amounts of sphingo-
myelin strongly increases entry kinetics and eﬃciency also at lower
temperatures.
In line with these observations, it had been shown that the DNA
methyltransferase inhibitor decitabine increases the sensitivity of drug-
resistant cancer cells to chemotherapeutics by decreasing the sphingo-
myelin content in the plasma membrane [36]. On the other hand, it was
not possible to recapitulate the diﬀerences in membrane permeation
using large unilamellar vesicles formulated with/without sphingomye-
lin. R9 showed a good penetration that was about 30% of the one
observed for the “gold standard” TP1. The relative activities of R9 and
penetratin followed the same order as reported for plasma membrane-
derived vesicles [37]. Instead of TP1, in this publication the hydro-
phobic CPP TP10 was used which showed the highest penetration. It
was also demonstrated that membrane proteins play an important role
in the direct membrane permeation of R9 in line with the lack of
penetration in our vesicle experiments. Further research will be needed
in order to understand how membrane proteins aﬀect the membrane
order in a way that enables peptide penetration.
To obtain information on the molecular processes associated with
the induction of nucleation zones, we performed for the ﬁrst time
whole-cell patch-clamp recordings simultaneously with time-lapse
confocal microscopy. Instead of studying the eﬀect of the CPP with
protocols adequate for single-channel recordings [38,39], we were
interested in the impact of the peptide on the whole-cell membrane
potential. These recordings revealed that in HeLa cells NZ formation
coincided with a strong membrane hyperpolarisation which was absent
in HEK cells. This ﬁnding was very surprising since a sudden inﬂux of a
polycation should be associated with a depolarization. Currently, the
molecular basis for this hyperpolarisation is unclear. Calcium-gated
potassium channels are a candidate mediator [40]. Another possibility
is that hyperpolarisation is a consequence of ceramide formation
[41,42]. However, the hyperpolarization induced by external addition
Fig. 6. Monitoring the membrane potential for the nucleation zone-dependent uptake of R9 simultaneously with confocal microscopy. (A) Representative membrane voltage (Vmem)
recording (whole-cell, current clamp) from a HeLa cell together with exemplary images from simultaneous time-lapse confocal microscopy. Incubation with gramicidin A (red horizontal
bar; 8 min, 1 μM) induces depolarization. Subsequent addition of bSMase (blue horizontal bar; 10 min, 1600 mU/mL) and incubation with ﬂuorescein-labelled R9 (green horizontal bar;
10 μM) does not substantially aﬀect membrane potential. Grey bars at the beginning and end of the recording indicate incubation with HEPES-buﬀered extracellular control solution. In
ﬂuorescence micrographs, the position of the patch pipette is indicated (lines), numbers correspond to timepoints during the electrophysiological recording. In the electrophysiological
recording, the horizontal line indicates membrane potential at−50 mV. (B) Enlargement of A illustrating R9 uptake and membrane potential over time. Positions of roman numerals in
the voltage trace correspond to the respective ﬂuorescence images. Washout of ﬂuorescein-labelled R9 (VIII) reveals the strong peptide uptake by the analyzed cell. Membrane potential at
−25 mV is indicated by the horizontal line. Scale bars denote 20 μm (A) and 10 μm (B). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
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of sphingomyelinase was less pronounced and showed much slower
kinetics than the one observed upon peptide addition (Supplemental
Fig. 8). It is, however, not clear yet, whether the hyperpolarization is
directly associated with sphingomyelinase activation or an independent
consequence of the interaction of the peptide with the plasma mem-
brane. Following depolarization and ceramide formation, direct mem-
brane permeation occurred without any changes in membrane poten-
tial. The restriction of the hyperpolarization to HeLa cells indicates that
a resistant membrane is a prerequisite for the peptide-induced hyper-
polarization. One may conceive that the membrane potential enhances
peptide accumulation at the plasma membrane which contributes to the
triggering of NZ-dependent import. This hypothesis is supported by the
ﬁnding that gramicidin A-induced depolarization inhibits NZ forma-
tion. The fact that depolarization aﬀected neither the uptake route nor
uptake eﬃciency in HEK cells demonstrates that direct translocation at
low concentrations and NZ-dependent uptake are fundamentally dif-
ferent mechanisms. The absence of depolarization upon peptide entry
in HeLa cells provides further evidence that translocation does not
compromise membrane integrity. This is in line with the exclusion of
propidium iodide as another measure for membrane integrity [8].
As shown before, nucleation zone-dependent uptake is restricted to
arginine-rich CPPs [8]. Also following sphingomyelinase treatment, no
penetration was observed for the amphipathic CPP penetratin, demon-
strating that this peptide does not possess the same capacity as R9 to
cross the lipid bilayer (Supplemental Fig. 9). One interesting concept in
lipid research is the spontaneous formation of pores or lipid ion
channels [43]. The propensity of ions to traverse such pores follows
the chaotropic series, which readily provides an explanation for a
nucleation zone-dependent entry being restricted to arginine-rich CPPs.
Importantly, our experiments refute the role of membrane potential
in peptide uptake. Once the plasma membrane is permissive for peptide
translocation, the concentration gradient is suﬃcient to drive import
into the cytoplasm. As an alternative to gramicidin A, in some studies,
Vmem was changed by incubating cells with a potassium-rich buﬀer
resulting in inhibition of peptide uptake [3,19,44]. Rothbard et al.
showed that inducing hyperpolarization by valinomycin increased the
uptake of R8 in Jurkat cells, whereas a depolarization by gramicidin A
decreased uptake [19]. While our results for gramicidin A are in line
with previous data, at this point, we do not have an explanation for the
discrepancies of the valinomycin experiments.
Notably, removal of the glycocalyx did not aﬀect the uptake
mechanism. In an attempt to separate the contribution of GAGs and
sphingomyelin, Bechara et al. showed that sphingomyelinase treatment
increased uptake more strongly for wildtype cells compared to GAG-
deﬁcient cells [45]. However, these authors solely measured the total
amount of internalized peptide without determining the involved
uptake mechanism, which is, in our opinion, the most important factor.
In summary, we show that for peptide entry two diﬀerent states of
the plasma membrane can be discriminated. A resistant state which
does not permit direct membrane permeation, and a permissive state for
which permeation occurs independent of membrane potential. By
changing the lipid composition, notably conversion of sphingomyelin
into ceramide, the resistant state can be converted into a permissive
state. It will be very interesting to relate import eﬃciencies in vivo to
sphingomyelin content and explore this concept also with regard to
other types of molecular scaﬀolds for cytoplasmic delivery.
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